With the prevalence of, and prescriptions for, attention-deficit/hyperactivity disorder (ADHD) rising steeply in the past decade, experts are looking at whether current diagnostic practices and definitions are helping or hindering the situation.
With the prevalence of, and prescriptions for, attention-deficit/hyperactivity disorder (ADHD) rising steeply in the past decade, experts are looking at whether current diagnostic practices and definitions are helping or hindering the situation.
Researchers from Australia and the Netherlands note in a recent analysis that the prevalence of ADHD in the United States rose from 6.9% in 1997 to 9.5% in 2007, and that similar escalations have occurred in the Netherlands and other countries.
They also point out that up to 86% of US children diagnosed with ADHD are described as having only a mild or moderate form of the disorder, yet no hard and fast definition for mild or moderate ADHD exists in the United Kingdom, in Australian or US guidelines, or in the Diagnostic and Statistical Manualof Mental Disorders, Fifth Edition: DSM-5.
The investigators say that fewer children would be diagnosed with ADHD if practitioners used the International Classification of Diseases definition, but that most health care providers use the DSM.
They note that part of the problem is that severity of ADHD criteria is subjective. In addition, longitudinal data on the prognosis and effects of treatment are limited, and no one wants to reduce the threshold for diagnosing ADHD if it means devaluing the diagnosis in patients with serious problems.
Although severe cases of ADHD are generally easy to diagnosis, those of a mild to moderate nature-the bulk of the cases-can be difficult, the researchers say. To reduce the risk of overdiagnosis without risking undertreatment of those who really need help, the researchers suggest a conservative, stepped diagnostic approach, similar to that recommended by UK guidelines, that advocates a watchful waiting period of 10 weeks, referral of parents to a parent training program, and then referral of the child to secondary care if symptoms persist. In addition, they propose 5 steps of care before definitively diagnosing ADHD.
The Centers for Disease Control and Prevention reports that a full two-thirds of children with a current ADHD diagnosis are taking medication for the disorder.
To get weekly clinical advice for today's pediatrician, subscribe to the Contemporary Pediatrics eConsult.
Exome sequencing should be used for diagnosing cerebral palsy
October 13th 2023A systematic review and meta-analysis found that such sequencing indeed has an equivalent high genetic diagnostic yield in cerebral palsy, which supports including this neurodevelopmental disorder among those for which diagnostic exome sequencing should be used.
Is ADHD associated with shorter-than-expected height?
October 10th 2023To assess the role of familial factors, investigators analyzed data for a family-based group created from another Swedish national register that included 833,172 individuals without ADHD with different levels of relatedness to the individuals with ADHD and a group of matched controls.
Associations between prenatal metal mixture exposure and negative infant outcomes
September 19th 2023Francheska M. Merced-Nieves, PhD, Assistant professor, Departments of Pediatrics and the Institute for Exposomic Research of Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, explains the associations prenatal exposure to a metal mixture and the potential negative effects for the infant.